Ceftobiprole in the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infections
Clinical trial NCT03137173 · COMPLETED
Trial details
- NCT number
- NCT03137173
- Sponsor
- Basilea Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-19
- Primary completion
- 2019-04-22
- Enrollment
- 679
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.